Dermatology Grand Rounds
Dermatology Lecture Hall
Wednesday, Sep. 21st, 8am-12pm
676 North Saint Clair Street, Suite 1600 (16th Floor)
Oncofertility: Bench to Bedside to Babies
Teresa K Woodruff, PhD
Director, Women’s Health Research Institute
Chief, Division of Obstetrics and Gynecology-Reproductive Science in Medicine
Thomas J. Watkins Memorial Professor of Obstetrics and Gynecology
Dr. Woodruff is the Thomas J. Watkins Professor of Obstetrics & Gynecology, the Vice Chair of Research (OB/GYN), and the Chief of the Division of Reproductive Science in Medicine, Feinberg School of Medicine. She is an internationally recognized expert in ovarian biology and, in 2006, coined the term “Oncofertility” to describe the merging of two fields: oncology and fertility. She now heads the Oncofertility Consortium, an interdisciplinary team of biomedical and social scientist experts from across the country.
She developed the concept for a National Physicians Cooperative in Oncofertility (NPC) in order to link medical practices interested in fertility preservation protocols. Dr. Woodruff also serves as the founding director of the Women's Health Research Institute, which has as its mission ‘science to care’ and ensuring that sex and gender are part of the research mission. Because of her work in inclusion, she was recently interviewed by Leslie Stahl and was highlighted on a 60 Minutes report and has written extensively on inclusion of sex and gender in science and medicine (PNAS, Nature). She was named to the Time Magazine 2013 list of the Worlds Most Influential People as the only scientist on the list and was voted 112th.
Pathogenesis, clinical developments, and novel treatment approaches in Cutaneous Lupus
Victoria P. Werth, MD
Chief, Dermatology, Philadelphia V.A. Hospital
Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center
Professor of Medicine
Dr. Werth is a Professor of Dermatology at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center. She received her MD from John Hopkins University in, completed her residency at the New York University Medical Center and Northwestern Medical Center and her fellowship at New York Medical Center.
She is an internist and dermatologist with a practice devoted to autoimmune skin diseases. She has guided development and validation of disease severity tools currently being used in lupus, dermatomyositis, and autoimmune blistering disease studies. She is leading a multicenter collaborative, web-based database to collect prospective information on patients with skin and systemic manifestations of lupus erythematosus. This is the first systematic epidemiologic study of cutaneous lupus erythematosus in the United States. With the information collected on now over 350 patients at the University of Pennsylvania alone, we have performed the first prospective evaluations of cutaneous lupus erythematosus in order to assess disease severity, quality of life, and response to treatment, as well as complete validation studies of the CLASI, a disease severity tool for cutaneous lupus. Her investigational laboratory studies relate to biomarkers in cutaneous lupus and ultraviolet light effects on skin. Recent studies have examined mechanistic effects of therapeutics in CLE, as well as subset-specific expression of interferon signatures. Dr. Werth is a member of the Medical & Scientific Committee of the Lupus Foundation of America, Associate Editor for the Lupus Science & Medicine journal, and her research has been funded by the Alliance for Lupus Research, Lupus Foundation of America, Lupus Research Institute, NIH, and the VA.
Overall meeting objectives:
At the conclusion of this activity, participants should be able to:
1. Discuss new technology used in addressing dermatologic problems.
2. Understand the choices and risks for treating skin disease.
3. Discuss the ethical issues that arise in patient care.
4. Recognize the relevance of new laboratory discoveries to clinical issues.
The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement:
The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure: Amy S. Paller, MD/MS has disclosed the following relevant financial relationships:
Serves as a consultant (with honoraria ) for the following companies: AbbVie, Anacor Pharmaceuticals, Inc., Celgene Corporation, Chugai Pharma, Galderma Laboratories, L.P. LEO Pharma US, Novartis Pharmaceuticals Corp., Onset Dermatologics, Promius Pharma, LLC., Scioderm, Shire, and Stiefel a GSK company.
Serves as a Principal Investigator (no honoraria) for the following companies: Amgen, Anacor Pharmaceuticals, Inc., Scioderm, and TopMD.
FSM’s listed CME Leadership and Staff have nothing to disclose: John X. Thomas, Jr., PhD, Sr. Associate Dean for Medical Education, Genevieve Napier, CME Director, Jen Banys, Michelle Mallery, and Tristan Brown, CME Project Specialists.
Teresa K Woodruff, PhD has nothing to disclose
Victoria P. Werth, MD discloses the following:
Serves as a board member with honoraria: Celegen
Serves as a consultant for: Medimmune
Serves as a consultant with honoraria: Biogen, Janssen
Has received a grant from: Celgene, Janssen, Astra-Zenica
Sponsored by: Department of Dermatology
Upcoming Dermatology Events
October Grand Rounds Schedule Information
Wednesday, Oct. 19th, 8am-12pm
676 North Saint Clair Street
Brett King, MD, MPH
Assistant Professor of Dermatology; Medical Director, Yale Dermatology-Middlebury
Dr. Brett King is Assistant Professor of Dermatology, specializing in skin diseases recalcitrant to first-line therapies. He also conducts investigator-initiated clinical trials to try to identify new treatments for skin disorders.